AUGX - Augmedix - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05105P1075
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California. Web URL: https://www.augmedix.com
Drawdown (Underwater) Chart
AUGX Stock Overview
| Market Cap in USD | 116m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC SubIndustry | Health Care Equipment |
| TER | 0.00% |
| IPO / Inception | 2021-03-31 |
AUGX Stock Ratings
| Growth 5y | -52.1 |
| Fundamental | -53.3 |
| Dividend | 0.00 |
| Rel. Performance vs Sector | -8.84 |
| Analysts | 3.50/5 |
| Fair Price Momentum | 2.00 USD |
| Fair Price DCF | - |
AUGX Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | 0.00% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 0.0% |
AUGX Growth Ratios
| Growth 12m | -52.81% |
| Growth Correlation 12m | -84% |
| Growth Correlation 3m | 95% |
| CAGR 5y | -19.32% |
| CAGR/Mean DD 5y | -0.34 |
| Sharpe Ratio 12m | -0.34 |
| Alpha vs SP500 12m | -67.67 |
| Beta vs SP500 5y weekly | 0.28 |
| ValueRay RSI | 72.86 |
| Volatility GJR Garch 1y | 5.23% |
| Price / SMA 50 | 2.17% |
| Price / SMA 200 | -20.88% |
| Current Volume | 0k |
| Average Volume 20d | 62.3k |
External Links for AUGX Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of AUGX stocks?
As of October 22, 2024, the stock is trading at USD 2.35 with a total of 0 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.43%, over three months by +3.52% and over the past year by -54.01%.
As of October 22, 2024, the stock is trading at USD 2.35 with a total of 0 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.43%, over three months by +3.52% and over the past year by -54.01%.
What are the forecast for AUGX stock price target?
According to ValueRays Forecast Model, AUGX Augmedix will be worth about 2.2 in October 2025. The stock is currently trading at 2.35. This means that the stock has a potential downside of -7.66%.
According to ValueRays Forecast Model, AUGX Augmedix will be worth about 2.2 in October 2025. The stock is currently trading at 2.35. This means that the stock has a potential downside of -7.66%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 2.9 | 24.3 |
| Analysts Target Price | 6.6 | 182 |
| ValueRay Target Price | 2.2 | -7.66 |